Neurotransmitters in Multiple Sclerosis: Glutamate, GABA, Dopamine & Serotonin
Multiple sclerosis (MS) is an autoimmune disease attacking the central nervous system. While neurotransmitter involvement is an active research area, evidence suggests several key systems are disrupted.
Key Neurotransmitter Alterations in MS
Glutamate (Excitatory)
- Primary excitatory neurotransmitter
- Dysregulation → excitotoxicity → neuronal damage
- Implicated in MS pathogenesis and symptom progression
GABA (Inhibitory)
- Primary inhibitory neurotransmitter
- Reduced levels observed in MS patients
- Imbalance contributes to hyperexcitability and neurodegeneration
Dopamine
- Involved in movement, reward, motivation
- Reduced levels in certain brain regions
- May contribute to fatigue, coordination issues, mood disturbances
Serotonin
- Regulates mood, sleep, appetite
- Altered levels in MS
- May underlie high rates of depression and anxiety in MS
Therapeutic Implications
Research explores drugs targeting glutamate modulation (e.g., riluzole) and dopamine enhancement. However, neurotransmitter-based therapies remain investigational. Current MS treatments focus on immunomodulation.
Understanding neurotransmitter dynamics may yield future symptomatic and neuroprotective treatments.
Multiple Sclerosis - Related Articles
- Multiple Sclerosis (MS) Medications
- Natural Relief for Multiple Sclerosis Symptoms: Home Remedies & Management
- Multiple Sclerosis in Women: Symptoms, Causes & Understanding
- Multiple Sclerosis and Menopause: Understanding the Connection
- Multiple Sclerosis (MS): Symptoms, Causes & Understanding
- Multiple Sclerosis (MS): Symptoms, Diagnosis & Management
- Miosis: Causes, Symptoms, and Medical Information
